TAZVERIK ® is a registered trademark of Epizyme Inc., an Ipsen company.

A drug-resistant type of bacteria that has adapted to health care settings evolved in the past several years to weaponize an antimicrobial genetic tool, eliminating its cousins and replacing them as ...

A deadly hospital superbug has evolved into a global force by weaponizing a genetic tool to wipe out its microbial ...

A new study suggests that fluoxetine, commonly known as Prozac, may do more than treat depression. Researchers at the Salk ...

During a health-focused event in New York on Tuesday, Google announced the development of a new collection of “open” AI ...

British investment firm SV Health Investors has secured $250 million to go toward the development of first-in-class ...

Statistics show hundreds of thousands of systemic bacterial and fungal infections are diagnosed each year in the United ...

The joint initiatives among Nvidia, Google, and Alphabet, span infrastructure and open model optimizations, offer major ...

In a world where scientific challenges are growing more complex by the day, researchers are turning to an unlikely partner: ...

Rutgers researchers found that increased brown fat improves longevity and exercise capacity in mice. They aim to develop a ...

LUND, SE / ACCESS Newswire / March 20, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class i ...

Nvidia Corporation, Alphabet Inc., and Google LLC have announced a new collaboration, which is aimed at advancing artificial ...